Identifying Rare Genetic Variants of Immune Mediators as Risk Factors for Autism Spectrum Disorder

Autism spectrum disorder (ASD) affects more than 1% of children, and there is no viable pharmacotherapeutic agent to treat the core symptoms of ASD. Studies have shown that children with ASD show changes in their levels of immune response molecules. Our previous studies have shown that ASD is more c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Chunquan, Yin, Zhaoqing, Liu, Aiping, Wang, Hui, Zeng, Shujuan, Wang, Zhangxing, Qiu, Huixian, Li, Shijun, Zhou, Jiaxiu, Wang, Mingbang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223212/
https://www.ncbi.nlm.nih.gov/pubmed/35741860
http://dx.doi.org/10.3390/genes13061098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223212/
https://www.ncbi.nlm.nih.gov/pubmed/35741860
http://dx.doi.org/10.3390/genes13061098

Ejemplares similares